missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human ABCG2 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 8 publications
Marca: R&D Systems MAB995-100
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
ABCG2/CD338 Monoclonal specifically detects ABCG2/CD338 in Human samples. It is validated for Flow Cytometry, Immunocytochemistry, CyTOF-ready.
Especificaciones
| ABCG2/CD338 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| ABCG2 | |
| 3T3 cells transduced with human ABCG2 | |
| 100 μg | |
| Primary | |
| Detects human ABCG2 in flow cytometry and immunocytochemistry. | |
| Human | |
| Supernatant |
| Flow Cytometry, Immunocytochemistry, CyTOF | |
| 5D3 | |
| Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
| ABC transporter, ABC15, ABCP, ABCPMGC102821, ATP-binding cassette sub-family G member 2, ATP-binding cassette transporter G2, ATP-binding cassette, sub-family G (WHITE), member 2, BCRP, BCRP1, BCRPMRX, BMDP, Breast cancer resistance protein, CD338, CD338 antigen, CDw338, EST157481, mitoxantrone resistance protein, Mitoxantrone resistance-associated protein, MXR, MXRMXR1, placenta specific MDR protein, Placenta-specific ATP-binding cassette transporter | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 9429 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction